Characterization of ibrutinib‐sensitive and ‐resistant mantle lymphoma cellsJiao Ma, Y. Lynn Wang, Pin Lu et al.|British Journal of Haematology|2014Cited by 89
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemiaMayumi Sugita, Mónica L. Guzmán, Swathi Merugu et al.|npj Precision Oncology|2021Cited by 36
Histiocytic Sarcoma Following B-Lymphoblastic Leukemia/LymphomaJulia T. Geyer, Wayne Tam, Nuri Yiğit et al.|American Journal of Clinical Pathology|2019Cited by 8
Targeting the Epichaperome As an Effective Precision Medicine Approach in a Novel PML-SYK Fusion Acute Myeloid LeukemiaGail J. Roboz, Mónica L. Guzmán, Mayumi Sugita et al.|Blood|2018Cited by 3
Metadata record for the manuscript: Targeting the Epichaperome As an Effective Precision Medicine Approach in a Novel PML-SYK Fusion Acute Myeloid LeukemiaMayumi Sugita, Mónica L. Guzmán, David Wilkes et al.|Figshare|2021Cited by 1